Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
Auriga Reiterates a 'Buy' on Jazz Pharmaceuticals (JAZZ); Lifting Numbers on 'Beat & Raise'
Auriga Reiterates a 'Buy' on Jazz Pharmaceuticals (JAZZ) After Call With Patent Attorney
Auriga Maintains a 'Buy' on Jazz Pharmaceuticals (JAZZ); Can Prialt Reach $150 Mln in Revenue by 2016?
Auriga Labels Jazz Pharmaceuticals (JAZZ) as Successful Orphan Drug Story; Starts Coverage at 'Buy'